Jim Simons Renaissance Technologies
AUM
$75.2B
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+10.31%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$80.1B
AUM Growth
+$80.1B
(-0.34%)
Cap. Flow
-$5.79B
Cap. Flow
% of AUM
-7.22%
Top 10 Holdings %
Top 10 Hldgs %
12.21%
Holding
3,960
New
702
Increased
989
Reduced
1,705
Closed
554
Top Buys
| 1 |
Amazon
AMZN
|
$842M |
| 2 |
NVIDIA
NVDA
|
$559M |
| 3 |
Microsoft
MSFT
|
$420M |
| 4 |
Apple
AAPL
|
$389M |
| 5 |
Moderna
MRNA
|
$365M |
Top Sells
| 1 |
Baidu
BIDU
|
$628M |
| 2 |
Tesla
TSLA
|
$424M |
| 3 |
Palo Alto Networks
PANW
|
$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$415M |
| 5 |
AT&T
T
|
$389M |
Sector Composition
| 1 | Healthcare | 19.94% |
| 2 | Technology | 19.65% |
| 3 | Consumer Staples | 10.63% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$250B
| $2.03B | 2.53% | 24,181,071 -665,600 | -3% | -$55.8M |
|
2
VeriSign
VRSN
$25.4B
| $1.1B | 1.38% | 4,841,290 -27,024 | -0.6% | -$6.15M |
|
3
Zoom
ZM
$24.4B
| $1.03B | 1.29% | 2,662,863 +142,000 | +6% | +$55M |
|
|
4
NVIDIA
NVDA
$4.26T
| $929M | 1.16% | 1,160,793 +698,500 | +151% | +$559M |
|
|
5
Amazon
AMZN
$2.44T
| $897M | 1.12% | 260,655 +244,800 | +1,544% | +$842M |
|
6
Target
TGT
$43.6B
| $870M | 1.09% | 3,600,559 +14,500 | +0.4% | +$3.51M |
|
7
Atlassian
TEAM
$47B
| $846M | 1.06% | 3,293,360 -48,060 | -1% | -$12.3M |
|
|
8
Moderna
MRNA
$9.31B
| $749M | 0.94% | 3,188,454 +1,552,925 | +95% | +$365M |
|
9
Kroger
KR
$44.5B
| $679M | 0.85% | 17,731,571 +557,500 | +3% | +$21.4M |
|
10
Monster Beverage
MNST
$60.9B
| $656M | 0.82% | 7,177,560 -779,200 | -10% | -$71.2M |
|
11
Franco-Nevada
FNV
$35.9B
| $634M | 0.79% | 4,369,790 -467,600 | -10% | -$67.8M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $578M | 0.72% | 3,147,521 -180,600 | -5% | -$33.2M |
|
13
Domino's
DPZ
$15.5B
| $573M | 0.72% | 1,228,025 +291,600 | +31% | +$136M |
|
14
Molina Healthcare
MOH
$9.7B
| $569M | 0.71% | 2,248,465 -217,950 | -9% | -$55.2M |
|
|
15
Microsoft
MSFT
$3.77T
| $561M | 0.7% | 2,069,184 +1,549,000 | +298% | +$420M |
|
|
16
Apple
AAPL
$3.46T
| $559M | 0.7% | 4,078,632 +2,841,100 | +230% | +$389M |
|
17
United Therapeutics
UTHR
$13.8B
| $558M | 0.7% | 3,110,191 -97,400 | -3% | -$17.5M |
|
18
Hershey
HSY
$37B
| $556M | 0.69% | 3,192,466 -168,795 | -5% | -$29.4M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $524M | 0.65% | 1,678,923 -101,200 | -6% | -$31.6M |
|
20
Vodafone
VOD
$28.7B
| $511M | 0.64% | 29,809,976 -2,500,100 | -8% | -$42.8M |
|
21
Bristol-Myers Squibb
BMY
$95.7B
| $488M | 0.61% | 7,305,925 +333,738 | +5% | +$22.3M |
|
|
22
Alphabet (Google) Class A
GOOGL
$2.56T
| $483M | 0.6% | 197,848 -16,500 | -8% | -$40.3M |
|
23
Herbalife
HLF
$1.03B
| $469M | 0.59% | 8,894,664 -140,100 | -2% | -$7.39M |
|
24
Biogen
BIIB
$19.4B
| $461M | 0.57% | 1,330,003 -608,159 | -31% | -$211M |
|
25
Vertex Pharmaceuticals
VRTX
$101B
| $459M | 0.57% | 2,277,284 -123,000 | -5% | -$24.8M |
|